Skip to Main content Skip to Navigation
Journal articles

Cholesterol metabolism and resistance to tamoxifen.

Abstract : The oncoprotein MUC-1 was shown to upregulate the transcription of genes encoding cholesterol and lipid metabolic enzymes and correlated with a resistance to Tamoxifen (Tam) despite the presence of estrogen receptor α in breast cancer tumors. The importance of this observation is supported by molecular studies on Tam suggesting two additional pharmacological targets involved in cholesterol metabolism. These observations demonstrate the potential importance of cholesterol and lipid metabolism in the pharmacology/therapeutic effects of Tam.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00743466
Contributor : Marc Poirot <>
Submitted on : Friday, October 19, 2012 - 9:43:10 AM
Last modification on : Tuesday, June 30, 2020 - 3:10:55 AM

Identifiers

Collections

Citation

Marc Poirot, Sandrine Silvente-Poirot, Ralph Weichselbaum. Cholesterol metabolism and resistance to tamoxifen.. Current Opinion in Pharmacology, Elsevier, 2012, 12 (6), pp.683-9. ⟨10.1016/j.coph.2012.09.007⟩. ⟨inserm-00743466⟩

Share

Metrics

Record views

257